Biosimilars – a risky bet?

By Taskin Ahmed

Pharma Deals Review: Vol 2009 Issue 3 (Table of Contents)

Published: 20 Mar-2009

DOI: 10.3833/pdr.v2009.i3.1080     ISSN: 1756-7874

Section: Editorial



The market for biosimilars will increase as more biologic drugs reach patent expiry within the next 10 years...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details